Breast Cancer Research (Mar 2024)

The FBXW7-binding sites on FAM83D are potential targets for cancer therapy

  • Xiaoyu Jiang,
  • Yuli Wang,
  • Lulu Guo,
  • Yige Wang,
  • Tianshu Miao,
  • Lijuan Ma,
  • Qin Wei,
  • Xiaoyan Lin,
  • Jian-Hua Mao,
  • Pengju Zhang

DOI
https://doi.org/10.1186/s13058-024-01795-9
Journal volume & issue
Vol. 26, no. 1
pp. 1 – 14

Abstract

Read online

Abstract Increasing evidence shows the oncogenic function of FAM83D in human cancer, but how FAM83D exerts its oncogenic function remains largely unclear. Here, we investigated the importance of FAM83D/FBXW7 interaction in breast cancer (BC). We systematically mapped the FBXW7-binding sites on FAM83D through a comprehensive mutational analysis together with co-immunoprecipitation assay. Mutations at the FBXW7-binding sites on FAM83D led to that FAM83D lost its capability to promote the ubiquitination and proteasomal degradation of FBXW7; cell proliferation, migration, and invasion in vitro; and tumor growth and metastasis in vivo, indicating that the FBXW7-binding sites on FAM83D are essential for its oncogenic functions. A meta-evaluation of FAM83D revealed that the prognostic impact of FAM83D was independent on molecular subtypes. The higher expression of FAM83D has poorer prognosis. Moreover, high expression of FAM83D confers resistance to chemotherapy in BCs, which is experimentally validated in vitro. We conclude that identification of FBXW7-binding sites on FAM83D not only reveals the importance for FAM83D oncogenic function, but also provides valuable insights for drug target.

Keywords